In an Alzheimer’s disease rat model, vitamin D analogue treatment significantly increased the Nrf2 expression and significantly decreased a lipid peroxidation marker, the malondialdehyde (MDA) levels compared to non-treated group [35]. Here, NFE2L2 is linked to early-onset autosomal dominant Alzheimer disease.